Deutsche Bank
LUMO

Deutsche Bank’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Deutsche Bank’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-33
Closed -$1K – 5828
2013
Q4 		$1K Hold
33
– – ﹤0.01% 5318
2013
Q3 		$1K Buy
+33
New +$5.31K ﹤0.01% 5461

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank's LUMO Position: Q3 2019 in Review

Deutsche Bank sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 780 shares — an estimated $10K sold.

Deutsche Bank first reported a position in LUMO in Q2 2013 and held it in 25 quarters. The position peaked at $6.33M in Q3 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

  • Deutsche Bank reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Deutsche Bank sold 780 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $10K.
  • Deutsche Bank first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 25 quarters.
  • Deutsche Bank's Lumos Pharma, Inc. Common Stock position peaked at $6.33M in Q3 2015.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.